No photo of Arja Pasternack

Arja Pasternack

20022019
If you made any changes in Pure these will be visible here soon.

Personal profile

Fields of Science

  • 3111 Biomedicine

International and National Collaboration Publications and projects within past five years.

Publications 2002 2019

Activin Receptor Ligand Blocking and Cancer Have Distinct Effects on Protein and Redox Homeostasis in Skeletal Muscle and Liver

Hentila, J., Nissinen, T. A., Korkmaz, A., Lensu, S., Silvennoinen, M., Pasternack, A., Ritvos, O., Atalay, M. & Hulmi, J. J., 18 Jan 2019, In : Frontiers in Physiology. 9, 16 p., 1917.

Research output: Contribution to journalArticleScientificpeer-review

Open Access
File

Systemic Blockade of ACVR2B Ligands Protects Myocardium from Acute Ischemia-Reperfusion Injury

Magga, J., Vainio, L., Kilpio, T., Hulmi, J. J., Taponen, S., Lin, R., Räsänen, M., Szabo, Z., Gao, E., Rahtu-Korpela, L., Alakoski, T., Ulvila, J., Laitinen, M., Pasternack, A., Koch, W. J., Alitalo, K., Kivela, R., Ritvos, O. & Kerkelä, R., 6 Mar 2019, In : Molecular therapy. 27, 3, p. 600-610 11 p.

Research output: Contribution to journalArticleScientificpeer-review

Open Access
File

Activin inhibition limits early innate immune response in rat kidney allografts-a pilot study

Palin, N. K., Savikko, J., Pasternack, A., Rintala, J. M., Kalra, B., Mistry, S., Kumar, A., Roth, M-P., Helin, H. & Ritvos, O., Jan 2017, In : Transplant International. 30, 1, p. 96-107 12 p.

Research output: Contribution to journalArticleScientificpeer-review

Open Access

Transglutaminase 2-specific coeliac disease autoantibodies induce morphological changes and signs of inflammation in the small-bowel mucosa of mice

Kalliokoski, S., Piqueras, V. O., Frias, R., Sulic, A-M., Määttä, J. A. E., Kähkönen, N., Viiri, K., Huhtala, H., Pasternack, A., Laurila, K., Sblattero, D., Korponay-Szabo, I. R., Mäki, M., Caja, S., Kaukinen, K. & Lindfors, K., Mar 2017, In : Amino Acids. 49, 3, p. 529-540 12 p.

Research output: Contribution to journalArticleScientificpeer-review

Treatment with soluble activin type IIB-receptor improves bone mass and strength in a mouse model of Duchenne muscular dystrophy

Puolakkainen, T., Ma, H., Kainulainen, H., Pasternack, A., Rantalainen, T., Ritvos, O., Heikinheimo, K., Hulmi, J. & Kiviranta, R., 19 Jan 2017, In : BMC Musculoskeletal Disorders. 18, 11 p., 20.

Research output: Contribution to journalArticleScientificpeer-review

Open Access
File